Nephritis: Clinical Trials

6 trials for Nephritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 unknown. 6 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Unknown 6
Phase 24Unknown 4

Follow Nephritis: new trials by email Literature Review of Nephritis trials Research Report on Nephritis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of Safety and Efficacy of SGLT2is Among LN Patients
Dapagliflozin 10mg Tab orally once daily - Lupus Nephritis
Phase 1 / Phase 2UnknownAin Shams University502023-12-012023-11-02
Autologous Adoptive T Regulatory Cell Transfer in Autoimmune Diseases.
autologous adoptive T regulatory cell transfer. - Lupus Nephritis, Type 1 Diabetes Mellitus
Phase 1UnknownAin Shams University202022-12-012022-10-05
Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2
PurWet, FurFat, PurApo - Sequelae of; Infection, Post Infection Glomerulonephritis
Phase 1 / Phase 2UnknownAll Natural Medicine Clinic, LLC20002021-03-012021-05-26
Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis)
Intravenous injection - Focal Segmental Glomerulosclerosis
Phase 1UnknownRoyan Institute52015-05-012015-12-04
Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis
mesenchymal stem cell - Lupus Nephritis
Phase 1 / Phase 2UnknownOrgan Transplant Institute, China202008-05-012008-04-16
Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)
Allogeneic MSC (AlloMSC) - Refractory Systemic Lupus Erythematosus
Phase 1 / Phase 2UnknownNanjing Medical University202007-03-012008-06-17

Narrower conditions

Lupus Nephritis (4)  ·  Ageusia (1)  ·  Anosmia (1)  ·  Anxiety Disorders (1)  ·  Arthritis, Reactive (1)  ·  Bipolar Disorder (1)  ·  COVID-19 stress syndrome (1)  ·  Depression (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Gastroesophageal Reflux (1)  ·  Glomerulonephritis (1)  ·  Glomerulosclerosis, Focal Segmental (1)  ·  Guillain-Barre Syndrome (1)  ·  Heartburn (1)  ·  Hepatitis (1)

Broader conditions

Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Kidney Diseases (6)  ·  Male Urogenital Diseases (6)  ·  Urogenital Diseases (6)  ·  Urologic Diseases (6)  ·  Autoimmune Diseases (5)  ·  Glomerulonephritis (5)  ·  Immune System Diseases (5)  ·  Connective Tissue Diseases (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Lupus Erythematosus, Systemic (3)  ·  Arthritis (1)  ·  Arthritis, Infectious (1)

Interventions

Injections, Intravenous (1)  ·  dapagliflozin (1)  ·  empagliflozin (1)

Sponsors

Ain Shams University (2)  ·  All Natural Medicine Clinic, LLC (1)  ·  Nanjing Medical University (1)  ·  Organ Transplant Institute, China (1)  ·  Royan Institute (1)

Countries

China (2)  ·  Egypt (2)  ·  Iran (1)  ·  United States (1)

Top investigators

Cherry Kamel, Professor (1)  ·  Hamid Gourabi, PhD (1)  ·  Hassan Otukesh, MD (1)  ·  Howaida Al-Shennawi, Professor (1)  ·  Lingyun Sun, M.D. (1)  ·  Nasser Aghdami, MD,PhD (1)  ·  Rozita Hosseini, MD (1)  ·  Soroosh Shekarchian, MD (1)  ·  Wanzhu Hou, CMD (1)

Results publications

PMID 30428931, PMID 38334499, PMID 42001190